this company has survived on the cash reserves it had in the...

this company has survived on the cash reserves it had in the bank and income from its HRT product in Europe and the US, since 2016. has no or very little debt and the recent capital raising has been a one off. There has not been any capital raising that I know of, as I've been following this company for 7 years and been a shareholder for 3 and 1/2 years. As for companies that continually need to raise capital through the issuing of new shares, that does keep a company going , but dilutes the existing share holders, not a good thing at all. The recent capital raising the ACR has undertaken has come after near five years (,doggedly following a strategy that hasn't changed at all in that time) as the company gears up to launch new products. the hard work of getting to this point has been done. The main problem this company has is the " Market " has not forgotten nor forgiven ACR for its near implosion 5 years ago. This is a fundamentally very different company as of today. Jet